Company Eucris Pharma Business S.r.l. with Fiscal Code 41221548
recorded a turnover of 2024 of
119.569,
with a net profit of
68.404
and having an average number of employees of
1.
The company operates in the field of Intermedieri în comerţul specializat în vânzarea produselor cu caracter specific, n.c.a. having the NACE code 4618.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Eucris Pharma Business S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
-
32.384
52.728
62.778
64.841
103.312
119.569
Total Income - EUR
-
-
-
-
32.384
52.728
62.778
64.849
103.312
119.569
Total Expenses - EUR
-
-
-
-
17.230
29.225
39.809
44.743
48.212
48.606
Gross Profit/Loss - EUR
-
-
-
-
15.154
23.503
22.969
20.106
55.100
70.963
Net Profit/Loss - EUR
-
-
-
-
14.182
22.000
21.123
18.515
54.077
68.404
Employees
-
-
-
-
0
0
0
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 16.4%, from 103.312 euro in the year 2023, to 119.569 euro in 2024.
The Net Profit increased by 14.629 euro, from 54.077 euro in 2023, to 68.404 in the last year.
Check the financial reports for the company - Eucris Pharma Business S.r.l.
Financial Rating - EUCRIS PHARMA BUSINESS S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Eucris Pharma Business S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Eucris Pharma Business S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Eucris Pharma Business S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Eucris Pharma Business S.r.l. - CUI 41221548
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
-
-
709
417
27.204
28.533
22.474
15.753
Current Assets
-
-
-
-
14.709
39.075
39.611
43.531
73.542
70.306
Inventories
-
-
-
-
0
0
0
0
0
0
Receivables
-
-
-
-
13.099
38.550
39.360
43.335
73.112
67.598
Cash
-
-
-
-
1.610
525
251
197
431
2.709
Shareholders Funds
-
-
-
-
14.224
35.955
34.768
32.202
67.723
68.453
Social Capital
-
-
-
-
42
41
40
41
40
40
Debts
-
-
-
-
1.194
3.538
32.047
39.943
28.377
17.607
Income in Advance
-
-
-
-
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4618 - 4618"
CAEN Financial Year
4618
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
70.306 euro in 2024 which includes Inventories of
0 euro, Receivables of
67.598 euro and cash availability of
2.709 euro.
The company's Equity was valued at
68.453 euro, while total Liabilities amounted to
17.607 euro.
Equity increased by 1.108 euro, from 67.723 euro in 2023, to 68.453 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Eucris Pharma Business S.r.l.